Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
746,550
-
Share change
-
+46,889
-
Total reported value
-
$138,876,719
-
Put/Call ratio
-
37%
-
Price per share
-
$186.13
-
Number of holders
-
126
-
Value change
-
+$8,758,995
-
Number of buys
-
49
-
Number of sells
-
31
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2022
As of 31 Dec 2022,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
746,550 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Royal Bank of Canada, RAYMOND JAMES & ASSOCIATES, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, BROWN ADVISORY INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, and CITADEL ADVISORS LLC.
This page lists
127
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.